White label – Pompe disease - ClinicalTrials.eu

Study of Nivolumab and Relatlimab for Patients with Resectable Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Nivolumab
- Relatlimab
Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Lenvatinib
Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
+1
Study on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension

Not recruiting

3 1 1
Investigated Diseases:
- Pulmonary hypertension
Investigated Drugs:
- Ralinepag
+9
Study on Low Dose Rivaroxaban for Heart and Blood Vessel Disease in Patients with Advanced Kidney Disease or on Dialysis

Not recruiting

3 1
Investigated Diseases:
- Chronic kidney disease
Investigated Drugs:
- Rivaroxaban
Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Not recruiting

3 1 1
Investigated Diseases:
- Systemic candida
Investigated Drugs:
+1
Study on the Effects of DFV890 for Pain Relief in Patients with Knee Osteoarthritis

Not recruiting

2 1 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
Study on Zoledronic Acid for Patients with Hip Fractures: Evaluating Early Treatment Safety and Effectiveness

Not recruiting

3 1 1
Investigated Diseases:
- Hip fracture
Investigated Drugs:
- Zoledronic Acid
Study Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma

Not recruiting

3 1 1 1
Investigated Diseases:
- Malignant melanoma stage III
- Malignant melanoma
Investigated Drugs:
- Ipilimumab
- Nivolumab
Study of Entrectinib in Children and Adolescents with Advanced or Metastatic Solid Tumors or Primary CNS Tumors with No Satisfactory Treatment Options

Not recruiting

1 1 1
Investigated Diseases:
- Malignant mast cell neoplasm
Investigated Drugs:
- Entrectinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies